EQL Pharma

Research EQL Pharma (EQL.ST) on Bullrun: market cap SEK 677.70M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

TickerEQL.ST
ExchangeXSTO
CountrySweden
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
CurrencySEK
Market capSEK 677.70M
Financial periodQ2 2026
RevenueSEK 106.91M
Net income-SEK 16.75M
Free cash flow-SEK 26.52M
Gross margin16.7%

Valuation Snapshot

latest market cap is SEK 677.70M.

Valuation history

Year	Snapshot date	Market cap	P/E	Dividend yield	Annual dividend/share
2026	2026-10-06	SEK 677.70M	n/a	n/a	0

Dividend history

Latest trailing dividend snapshot: annual dividend/share 0 SEK.

About EQL Pharma

EQL Pharma AB (publ) engages in the development, marketing, and sale of generic medicines to pharmacies and hospitals in Sweden, Denmark, Norway, Finland, and the rest of Europe. It offers prescription drugs, including hospital products. EQL Pharma AB (publ) was incorporated in 2006 and is headquartered in Lund, Sweden.

Related stock research

Sweden stocks Sweden Healthcare stocks A-Z stock index

Other Healthcare stocks

BioGaia AB (publ) (BIOG-B) Cinclus Pharma (CINPHA) Cereno Scientific AB Series B (CRNO-B) Dicot AB (DICOT) Enzymatica publ AB (ENZY) Enorama Pharma AB (ERMA) Gabather AB (publ) (GABA) Klaria Pharma Holding (KLAR.ST) Moberg Pharma (MOB.ST) Nanexa AB (NANEXA) Newbury Pharmaceuticals AB (NEWBRY) ODI Pharma AB (publ) (ODI.ST)

Frequently asked questions

What is EQL Pharma's market cap?

EQL Pharma's market capitalization is SEK 677.70M.